Breast Cancer Archive - Seite 9 von 17 - IOZK

Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium

2013-08-01/in Breast Cancer, Dendritic Cells, International Publications /von 2013-08-01 / Breast 2013 Aug;22 Suppl 2:S96-9

Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCIS

2013-07-13/in Breast Cancer, Dendritic Cells, International Publications /von 2013-07-13 / Ann. Surg. Oncol. 2013 Oct;20(10):3233-9

Re-irradiation and hyperthermia after surgery for recurrent breast cancer

2013-06-03/in Breast Cancer, Hyperthermia, International Publications /von 2013-06-03 / Radiother Oncol 2013 Nov;109(2):188-93

Short-term hyperthermia promotes the sensitivity of MCF-7 human breast cancer cells to paclitaxel

2012-12-11/in Breast Cancer, Hyperthermia, International Publications /von 2012-12-11 / Biol. Pharm. Bull. 2013;36(3):376-83

[Immunotherapy with hyperthermia for advanced or recurrent breast cancer patients in whom standard therapy showed no effect or was refused]

2012-11-01/in Breast Cancer, Hyperthermia, International Publications /von 2012-11-01 / Gan To Kagaku Ryoho 2012 Nov;39(12):1766-9

Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer

2012-09-01/in Breast Cancer, Dendritic Cells, International Publications /von 2012-09-01 / Cancer Immunol Immunother 2012 Sep;61(9):1415-24

Reduced Newcastle disease virus-induced oncolysis in a subpopulation of cisplatin-resistant MCF7 cells is associated with survivin stabilization

2012-08-01/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2012-08-01 / Cancer Cell Int. 2012 Aug;12(1):35

Co-culture of apoptotic breast cancer cells with immature dendritic cells: a novel approach for DC-based vaccination in breast cancer

2012-04-26/in Breast Cancer, Dendritic Cells, International Publications /von 2012-04-26 / Braz. J. Med. Biol. Res. 2012 Jun;45(6):510-5

Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice

2012-03-07/in Breast Cancer, Dendritic Cells, International Publications /von 2012-03-07 / Breast Cancer Res. 2012 Mar;14(2):R39

HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ

2012-01-17/in Breast Cancer, Dendritic Cells, International Publications /von 2012-01-17 / Cancer 2012 Sep;118(17):4354-62